Baicheng Pharmaceutical: Announcement of Resolutions of the 20th Meeting of the Third Board of Supervisors
Baicheng Pharmaceutical: Announcement of Resolutions of the 24th Meeting of the Third Board of Directors
Baicheng Pharmaceutical: Articles of Association
Baicheng Pharmaceutical: Legal Opinion of Beijing Hairun Tianrui Law Firm on the granting of price adjustments to Hangzhou Baicheng Pharmaceutical Technology Co., Ltd., the fulfillment of ownership conditions during the second vesting period, and the abolition of some restricted shares
Baicheng Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the Third Board of Supervisors
Baicheng Pharmaceutical: Announcement of Resolutions of the 23rd Meeting of the Third Board of Directors
Baicheng Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the ownership of the first 2022 restricted stock incentive plan of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd., and part of the second vesting period of the reserved grant
Hangzhou Bio-Sincerity Pharma-Tech: Board of directors resolution announcement.
Hangzhou Bio-Sincerity Pharma-Tech: Special report on the use and placement of funds raised during the first half of 2024.
Hangzhou Bio-Sincerity Pharma-Tech: Sinolink Securities Co., Ltd.'s Continuous Supervision and Follow-up Report on Hangzhou Baicheng Pharmaceutical Technology Co., Ltd.'s 2024 Half-Yearly
Hangzhou Bio-Sincerity Pharma-Tech: Announcement of the Supervisory Board's resolution.
Hangzhou Bio-Sincerity Pharma-Tech: 301096 Baicheng Pharmaceutical Investor Relations Management Information 2024-005
Hangzhou Bio-Sincerity Pharma-Tech: Announcement on the opening of a special settlement account for cash management of raised funds
Baicheng Pharmaceutical: 2023 Board Work Report
Baicheng Pharmaceutical: 2023 Annual Audit Report
Baicheng Pharmaceutical: Working Rules for Independent Directors
Baicheng Pharmaceutical: Supervisory Board Resolutions Announcement
Baicheng Pharmaceutical: Independent Director's 2023 Debriefing Report (Li Huilin)
Baicheng Pharmaceutical: Independent Director's 2023 Debriefing Report (Hu Yongzhou)
Baicheng Pharmaceutical: Special Report on the Storage and Use of Funds Raised in 2023
No Data
No Data